Alex Aravanis

Alex Aravanis, a trailblazer in DNA analysis and co-founder of Moonwalk Biosciences, dives into the future of cancer detection and aging research. He discusses the revolutionary impact of liquid biopsies for early cancer diagnosis, exploring cell-free DNA's role in improving specificity and sensitivity. Aravanis also unpacks the fascinating interplay of epigenetics and aging, including how cellular reprogramming may reverse age-related changes. His insights illuminate the cutting-edge intersection of technology, genetics, and health.